pz-peptide has been researched along with atenolol in 1 studies
| Studies (pz-peptide) | Trials (pz-peptide) | Recent Studies (post-2010) (pz-peptide) | Studies (atenolol) | Trials (atenolol) | Recent Studies (post-2010) (atenolol) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 5,473 | 1,950 | 852 |
| Protein | Taxonomy | pz-peptide (IC50) | atenolol (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.7468 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, YB; Han, K; Lee, VH; Nishiura, A | 1 |
1 other study(ies) available for pz-peptide and atenolol
| Article | Year |
|---|---|
Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit.
Topics: Actins; Administration, Topical; Animals; Atenolol; Biological Transport; Calcium; Chelating Agents; Conjunctiva; Cornea; Cytochalasin B; Egtazic Acid; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Male; Oligopeptides; Propranolol; Rabbits; Sympatholytics; Tight Junctions | 1998 |